Agrawal N, Joanna Rongong SL, Halder S, Barua JK, Satsangi P, Halder AK, Samanta P. An institution-based non-randomised prospective study to estimate the efficacy and adverse effect profile of apremilast for moderate to severe refractory palmoplantar psoriasis. Int J Res Dermatol [Internet]. 2023 Apr. 27 [cited 2025 Nov. 20];9(3):111-6. Available from: https://www.ijord.com/index.php/ijord/article/view/1672